Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow MNCs in Pediatric IDCM
NCT02256501Phase 2Completed
- Start
- Jun 2013
- Primary completion
- Mar 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in idiopathic dilated cardiomyopathy (IDC). Started Jun 2013; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
idiopathic dilated cardiomyopathy (IDC)
Beyond the preview
Go deeper on NCT02256501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256501.